Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2003
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003030920A9 An antispasmodic agent spaced drug delivery system
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
06/26/2003WO2002006529A3 Detection and treatment of polycystic kidney disease
06/26/2003US20030120074 Cardioprotective phosphonates and malonates
06/26/2003US20030120045 Immobilization onto polyoxyethylene glycol
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119728 Stable, nasally, orally or sublingually applicable pharmaceutical preparation
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030118638 Oral pharmaceutical products containing 17 beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation
06/26/2003US20030118633 Treating unstable or overactive urinary bladder by administering an antimuscarinic agent and an estrogen agonist
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470030A1 2-guanidino-4-heterocyclylquinazolines
06/26/2003CA2469950A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP0969737B1 Pet food composition
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0803256B1 Drug for relieving side effects caused by immunosuppressants
06/25/2003EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1426301A Compositions for treatment and prevention of cardiovascular diseases
06/25/2003CN1425432A Urinary protein recovery pill
06/25/2003CN1425422A Medicine for curing diabetes and nephrosis and its preparing method
06/25/2003CN1425382A Product of ginsenoside for improving sextual function
06/25/2003CN1425377A Dibasic acid di (5-androstene-17-one-3 beta-hydroxy) ester used for preparing medicine
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/25/2003CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase
06/25/2003CN1112211C Medicine for treating lithiasis
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
06/24/2003US6583145 Thio-oxindole derivatives
06/24/2003US6583143 CRF receptor antagonists and methods relating thereto
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/19/2003WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114678 Cardioprotective phosphonates and malonates
06/19/2003US20030114677 Cardioprotective phosphonates and malonates
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114509 Prophylactic or therapeutic drug for renal diseases
06/19/2003US20030114505 Novel isoxazole and thiazole compounds and use thereof as drugs
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114425 Tiamenidine
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113803 Orphan receptor
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 562